LordsMed Boosts its Global Footprint with the Launch of an Export Section for Diagnostic Supplies

India Pharma Outlook Team | Thursday, 20 July 2023

 India Pharma Outlook Team

LordsMed, Lord's Mark Industries Pvt. Ltd.'s worldwide healthcare division, has announced the start of an export endeavour of diagnostic products to Nepal. The company's goal is to become a global leader in In-Vitro Diagnostics manufacturing and export. LordsMed has successfully created a huge network of over 300 distributor channels across India with a strong dedication to supplying excellent IVD products at a low cost.

The production facilities, which are located on the outskirts of Mumbai, can currently accommodate an amazing 1.7 crore diagnostic tests every month, encompassing a wide range of specialisations such as biochemistry, haematology, serology, fast tests, and urine strip tests. "We are thrilled to announce the launch of our Export Division and our first venture into Nepal," said Manav Teli, executive director of Lord's Mark Industries. Our goal has always been to become a global leader in IVD manufacturing and export, offering high-quality solutions at a reasonable price.

We are also expanding our reach to surrounding nations thanks to our advanced manufacturing facilities and broad distributor network. This is a huge step forward in our efforts to satisfy the healthcare requirements of a larger population. We are also delighted to investigate OEM prospects and expand our manufacturing capability, enabling universal diagnostic access." As Lord’s Mark Industries continues to strengthen its presence in the Indian market, the company is now strategically focusing on supplying neighbouring countries with its high-quality IVD products. Incorporated in 1998, Lord's Mark Industries has been delivering value to all stakeholders and partners by creating sustainable business to become globally recognized brand in diversified industries.

© 2024 India Pharma Outlook. All Rights Reserved.